A Single-arm, Interventional, Multi-center, Pilot Study to Evaluate the Efficacy of Oral Bisoprolol on Heart Rate Reduction in Chinese Chronic Heart Failure Patients With NYHA Class II - IV (Biso-CHF Study)
Phase of Trial: Phase IV
Latest Information Update: 02 Feb 2018
At a glance
- Drugs Bisoprolol (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- Acronyms Biso-CHF Study
- Sponsors Merck KGaA
- 12 Jan 2018 Planned End Date changed from 31 Jan 2019 to 31 Jan 2020.
- 23 May 2017 Planned End Date changed from 31 May 2019 to 31 Jan 2019.
- 23 May 2017 Planned primary completion date changed from 28 Feb 2018 to 31 Jan 2019.